Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

First-trimester maternal renin-angiotensin-aldosterone system activation and fetal growth and birthweight: the Rotterdam Periconceptional Cohort.

Reproductive biomedicine online·2022

Same author

Preconception and early-pregnancy risk prediction for birth complications: development of prediction models within a population-based prospective cohort.

BMC pregnancy and childbirth·2022

Same author

Associations of maternal angiogenic factors during pregnancy with alterations in cardiac development in childhood at 10 years of age.

American heart journal·2022

Same author

Innovative approach for first-trimester fetal organ volume measurements using a Virtual Reality system: The Generation R Next Study.

The journal of obstetrics and gynaecology research·2022

Same author

Twenty-year trends in the use of anti-seizure medication among pregnant women in the Netherlands.

Epilepsy & behavior : E&B·2022

Same author

Long-term association of pregnancy and maternal brain structure: the Rotterdam Study.

European journal of epidemiology·2022

Search research articles

Related Experiment Video

Updated: May 18, 2026

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

[Hepatocellular adenomas and pregnancy].

Mirelle E E Bröker¹, Susanna M van Aalten, Jan N M Ijzermans

¹Erasmus MC, Afd. Chirurgie, Rotterdam, the Netherlands. m.broker@erasmusmc.nl

Nederlands Tijdschrift Voor Geneeskunde

|September 21, 2012

Summary

Hepatocellular adenomas, benign liver tumors mostly in young women, pose risks during pregnancy due to hormone-induced growth and rupture. Careful management is crucial for these patients.

More Related Videos

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Published on: August 18, 2023

Related Experiment Videos

Last Updated: May 18, 2026

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Published on: August 18, 2023

Area of Science:

Hepatology
Oncology
Reproductive Medicine

Background:

Hepatocellular adenomas (HCAs) are benign liver tumors predominantly affecting young women.
Pregnancy in women with HCAs requires special attention due to potential risks associated with hormonal changes.

Observation:

Presents three cases of women with HCAs who were pregnant or planning pregnancy.
Highlights the complex clinical scenarios encountered in managing HCAs during pregnancy.

Findings:

Observed varied responses of HCA size during pregnancy; one patient showed growth, another stability.
A patient with a centrally located HCA was advised against pregnancy before intervention.

Implications:

Underscores the need for individualized management strategies for HCAs in pregnant or potentially pregnant women.
Emphasizes the importance of considering tumor location and hormonal influences in clinical decision-making for HCAs.